To determine the prognostic relevance of NLGN2 in breast cancer, patients from multiple breast cancer datasets (totally 1764 subjects) were classified into the NLGN2high and NLGN2low groups, and their survival was analyzed using KM Plotter (28). This evidence concerns the gene NLGN2 and breast carcinoma.